This inventor holds 1 USPTO granted patent. Top assignee: Hiroshima Institute of Life Sciences. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Hironori Nishitsuji: Innovator in Hepatitis B Research
Introduction
Hironori Nishitsuji is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of medical research, particularly in the fight against viral infections. His work focuses on developing innovative solutions to combat hepatitis B virus (HBV) infections.
Latest Patents
Nishitsuji holds a patent for a "Human NTCP-Binding Antibody Capable of Inhibiting Infection of Hepatitis B Virus (HBV) to Human Hepatocytes." This groundbreaking invention aims to provide a new therapeutic approach to prevent HBV from infecting liver cells, which is crucial for improving treatment options for patients.
Career Highlights
Nishitsuji is affiliated with the Hiroshima Institute of Life Sciences, where he conducts his research. His dedication to advancing medical science has led to the development of this important patent, showcasing his commitment to addressing public health challenges.
Collaborations
Nishitsuji collaborates with esteemed colleagues, including Mikako Shirouzu and Yushi Futamura. Their combined expertise enhances the research efforts at the Hiroshima Institute of Life Sciences, fostering innovation in the field.
Conclusion
Hironori Nishitsuji's work exemplifies the spirit of innovation in medical research. His patent for a human NTCP-binding antibody represents a significant advancement in the fight against hepatitis B. Through his contributions, he continues to pave the way for future breakthroughs in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile